News Channels

24 Jan 2019 Rigel Pharmaceuticals Enters Collaboration and License Agreement with Grifols, S.A. to Commercialize Fostamatinib in Europe
24 Jan 2019 Second Genome Doses First Patient In Phase 2 Clinical Study Of SGM-1019 For The Treatment Of Nonalcoholic Steatohepatitis (NASH)
24 Jan 2019 B-MoGen Biotechnologies and CytoSen Therapeutics partner on research collaboration to develop next generation Natural Killer Cells for human therapeutics
24 Jan 2019 Athersys Announces Positive Results From Its Exploratory Clinical Study of MultiStem® Cell Therapy for Treatment of Acute Respiratory Distress Syndrome (ARDS)
24 Jan 2019 Long-term survival analysis of the randomised Phase III study shows a clear clinical benefit of inolimomab in SR-aGvHD
24 Jan 2019 Basilea announces collaboration to study derazantinib and atezolizumab (Tecentriq®) in urothelial cancer
24 Jan 2019 Bavarian Nordic Advances Development of Equine Encephalitis Virus Vaccine
23 Jan 2019 Veru Initiates Clinical Trial for Proprietary, Novel, First-in-Class Drug for Advanced Prostate Cancer
23 Jan 2019 uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-130 in Huntington’s Disease
23 Jan 2019 Bio-Thera Solutions Announces Initiation of Phase III Clinical Trial for BAT1806, a Proposed Biosimilar of Actemra® (Tocilizumab)
23 Jan 2019 Rocket Pharmaceuticals Announces Clearance of IND for RP-A501 Gene Therapy for Danon Disease
23 Jan 2019 PeptiDream Announces New Peptide Drug Conjugate (PDC) Discovery Deal with Shionogi
23 Jan 2019 TaiwanJ Pharmaceuticals Announces Positive Results from Phase 2 Orphan Drug Designation Study of JKB-122 on Autoimmune Hepatitis (AIH)
23 Jan 2019 BioNTech to Acquire Antibody Generation Unit of MAB Discovery
23 Jan 2019 Oramed Initiates Phase I Oral GLP-1 Study Under IND
23 Jan 2019 Biohaven Receives FDA May Proceed Letter For Phase 3 Clinical Trial Of BHV-3241 For Multiple System Atrophy
23 Jan 2019 I-Mab Biopharma Receives U.S. FDA IND Clearance for Proprietary CD73 Antibody TJD5
23 Jan 2019 PrimeVax Immuno-Oncology Signs Exclusive Worldwide Dengue Virus License with US Army for Cancer Treatments
23 Jan 2019 FDA Accepts IND Application for Cerecor’s Investigational Drug CERC-801 for the treatment of PGM1 Deficiency
23 Jan 2019 Orchard Announces Publication by San Raffaele-Telethon Institute for Gene Therapy of OTL-300 Clinical Data for the Treatment of Transfusion-Dependent Beta-Thalassemia in Nature Medicine

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top